Skip to main content Skip to main navigation menu Skip to site footer

A challenging triple valve surgery for long-standing pulmonary hypertension in rheumatic heart disease: a case report

  • Cut Dhora Narenza ,
  • Yopie Afriandi Habibie ,


Background Pulmonary hypertension is an increase in the mean pulmonary arterial pressure, greater than 25mmHg at rest, or greater than 30mmHg while exercising. In valvular heart disease its presence indicates a decompensated state of the disease. Surgical interventions are the ultimate treatment for the correction of valvular heart disease.

Case Report A 38-year-old female was admitted to the Emergency Department (ER) with complaints of shortness of breath, chest pain, palpitations, and history of fainting. The patient was initially scheduled for aortic and mitral valve replacement and tricuspid valve repair at the end of year 2020. However, due to covid-19 pandemic, the patient was re-scheduled for surgery. On the 15th of June 2022, the patient was admitted to the ER of Zainoel Abidin General Hospital, and was consulted to the CTVS division. On the 17th of June 2022, the patient underwent a successful mitral valve replacement using mechanical St. Jude 29 mm valve, mechanical St. Jude 17 mm for aortic valve position, and tricuspid valve repair commissurotomy and using MC3 Edward ring annuloplasty. The patient was hospitalized for seven days and underwent successful first phase cardiac rehabilitation before discharge. The patient has since made remarkable improvements, establishing better quality of life.

Conclusion Reduced pulmonary pressures postoperatively are often modest, and persistent pulmonary hypertension (PH) is known to be common and an indicator of poor prognosis. For patients with long-standing pulmonary hypertension due to rheumatic heart disease, valve replacement surgery effectively reduces pulmonary hypertension caused by damage to the left heart valve.


  1. Krishnaet al. Correction to: Contemporary Diagnosis and Management of Rheumatic Heart Disease: Implications for Closing the Gap: A Scientific Statement From the American Heart Association. Circulation. 2021;143(23). Available from:
  2. Maeder MT, Weber L, Buser M, Gerhard M, Haager PK, Maisano F, et al. Pulmonary Hypertension in Aortic and Mitral Valve Disease. Front Cardiovasc Med. 2018;5:40. Available from:
  3. Pagnamenta A, Azzola A, Beghetti M, Lador F. Invasive haemodynamic evaluation of the pulmonary circulation in pulmonary hypertension. Swiss Med Wkly. 2017;147(2728). Available from:
  4. Buckle S. Pulmonary Hypertension: A Clinical Case Study. J Lung, Pulm & Respir Res. 2015;2(6). Available from:
  5. Magne J, Pibarot P, Sengupta PP, Donal E, Rosenhek R, Lancellotti P. Pulmonary Hypertension in Valvular Disease. JACC Cardiovasc Imaging. 2015;8(1):83–99. Available from:
  6. Mandras SA, Mehta HS, Vaidya A. Pulmonary Hypertension: A Brief Guide for Clinicians. Mayo Clin Proc. 2020;95(9):1978-1988. Available from: doi: 10.1016/j.mayocp.2020.04.039. PMID: 32861339.
  7. Chiu S-N, Lu C-W, Lin M-T, Chen C-A, Wu M-H, Wang J-K. Pulmonary Hypertension in Adult Congenital Heart Disease in Asia: A Distinctive Feature of Complex Congenital Heart Disease. J Am Heart Assoc. 2022/03/14. 2022;11(7):e022596–e022596. Available from:
  8. Weitsman T, Weisz G, Farkash R, Klutstein M, Butnaru A, Rosenmann D, et al. Pulmonary Hypertension with Left Heart Disease: Prevalence, Temporal Shifts in Etiologies and Outcome. Am J Med. 2017;130(11):1272–9. Available from:
  9. Kobayashi K, Uchida T, Kuroda Y, Yamashita A, Ohba E, Nakai S, et al. Right-sided double valve replacement in an adult patient who underwent surgery for pulmonary stenosis in childhood: a case report. J Cardiothorac Surg. 2020;15(1):170. Available from:
  10. Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, Jneid H, Krieger EV, Mack M, McLeod C, O'Gara PT, Rigolin VH, Sundt TM 3rd, Thompson A, Toly C. Correction to: 2020 ACC/AHA Guideline on the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2021;143(10). Available from:
  11. Okura H, Nakada Y, Nogi M, Ishihara S, Okamura A, Okayama S, et al. Prevalence of mitral annular calcification and its association with mitral valvular disease. Echocardiography. 2021;38(11):1907–12. Available from:
  12. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Fleisher LA, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135(25). Available from:
  13. Yu P-J, Mattia A, Cassiere HA, Esposito R, Manetta F, Kohn N, et al. Should high risk patients with concomitant severe aortic stenosis and mitral valve disease undergo double valve surgery in the TAVR era? J Cardiothorac Surg. 2017;12(1):123. Available from:
  14. Das De S, Nanjappa A, Morcos K, Aftab S, Butler J, Pathi V, et al. The effect of patient-prosthesis mismatch on survival after aortic and mitral valve replacement: a 10 year, single institution experience. J Cardiothorac Surg. 2019;14(1):214. Available from:
  15. Egger ML, Gahl B, Koechlin L, Schömig L, Matt P, Reuthebuch O, et al. Outcome of patients with double valve surgery between 2009 and 2018 at University Hospital Basel, Switzerland. J Cardiothorac Surg. 2022;17(1):152. Available from:
  16. Bermejo J, González-Mansilla A, Mombiela T, Fernández AI, Martínez-Legazpi P, Yotti R, et al. Persistent Pulmonary Hypertension in Corrected Valvular Heart Disease: Hemodynamic Insights and Long-Term Survival. J Am Heart Assoc. 2021/01/05. 2021;10(2):e019949–e019949. Available from:
  17. Patzelt J, Zhang W, Sauter R, Mezger M, Nording H, Ulrich M, et al. Elevated Mitral Valve Pressure Gradient Is Predictive of Long-Term Outcome After Percutaneous Edge-to-Edge Mitral Valve Repair in Patients With Degenerative Mitral Regurgitation ( MR ), But Not in Functional MR. J Am Heart Assoc. 2019/06/28. 2019;8(13):e011366–e011366. Available from:
  18. Pourafkari L, Ghaffari S, Ahmadi M, Tajlil A, Aslanabadi N, Nader ND. Pulmonary hypertension in rheumatic mitral stenosis revisited. Herz. 2016;42(8):746–51. Available from:
  19. Magne J, Mohty D, Piccardo A, Boulogne C, Deltreuil M, Petitalot V, et al. Impact of Pulmonary Hypertension on Outcome in Patients with Severe Aortic Stenosis and Preserved Left Ventricular Ejection Fraction. Clin Res Cardiol. 2017;106(7):542–50. Available from:
  20. Tang M, Liu X, Lin C, He Y, Cai X, Xu Q, et al. Meta-Analysis of Outcomes and Evolution of Pulmonary Hypertension Before and After Transcatheter Aortic Valve Implantation. Am J Cardiol. 2017;119(1):91–9. Available from:

How to Cite

Narenza, C. D. ., & Habibie, Y. A. (2023). A challenging triple valve surgery for long-standing pulmonary hypertension in rheumatic heart disease: a case report. Bali Medical Journal, 12(1), 404–409.




Search Panel

Cut Dhora Narenza
Google Scholar
BMJ Journal

Yopie Afriandi Habibie
Google Scholar
BMJ Journal